Autologous Peripheral Blood Stem Cell therapy (Seoul National University Hospital)

N/A

Report date: 2024/04/16 20:00:32

Base Information

Drug NameAutologous Peripheral Blood Stem Cell therapy (Seoul National University Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Source of cells > Peripheral blood-derivedCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cell replacementsImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsMyocardial Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesSeoul National University Hospital - Abu Dhabi
China Registration ClassN/A

Develop Information

Active CompaniesSeoul National University Hospital - Abu DhabiSeoul National University Hospital
Inactive CompaniesN/A
Active IndicationsMyocardial Infarction
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A